Replies to post #411035 on Elite Pharmaceuticals Inc (ELTP)

[HGiLS]

There is no IF...

Growing for at least next 2 years

[Pranksalot]

According to people calculation here, the stock is already undervalued without that drug approval already. It’s hard to time, just buy some shares each day if you’re afraid. That’s what I’m doing lol

[kayak_wench]

Our P/E is 23 with current price. That is with the earnings not including the already launched Methotrexate or Tylenol with cosine.

Now roll in the billion dollar opioid markets that WILL launch in the next three months. Unless of course the at least 3 billion dollar Vyvanse gets approved in a few weeks as expected.

Meaning Elite is still a bargain at $0.50!!!

[kayak_wench]

Apparently a lot of people do find investing now appealing. You aren’t looking at numbers that matter to decide whether price is reasonable now, you’re looking at change in price alone. This company has been undervalued for a long time. It doesn’t matter that we are at 52 week high if future revenues that will continue to fuel growth are definitely going to occur very soon…and they are. That is ignoring whether Vyanse is approved in Nov.

Throw in another billion dolllar plus product under going BE that could be announced this quarter and the current price starts looking cheap.